Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3726
CALL
Nabors Industries
NBR
$1.39B
| $2.25M | ﹤0.01% |
385,891
+95,008
| +33% | +$8.26M |
|
3727
CALL
Nano X Imaging
NNOX
$65.2M
| $2.25M | ﹤0.01% |
+100,000
| New | +$2.63M |
|
3728
Sable Offshore Corp
SOC
$861M
| $2.25M | ﹤0.01% |
231,245
+75,600
| +49% | +$731K |
|
3729
PUT
Southern Copper
SCCO
$177B
| $2.25M | ﹤0.01% |
+43,666
| New | +$2.5M |
|
3730
CALL
Owlet
OWLT
$146M
| $2.24M | ﹤0.01% |
+28,643
| New | +$3.2M |
|
3731
Evolution Petroleum
EPM
$131M
| $2.24M | ﹤0.01% |
394,289
-232,446
| -37% | -$1.04M |
|
|
KAIR
3732
DELISTED
Kairos Acquisition Corp. Class A Ordinary Shares
KAIR
| $2.24M | ﹤0.01% |
231,417
-23,808
| -9% | -$231K |
|
|
FMTX
3733
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $2.24M | ﹤0.01% |
96,425
-161
| -0.2% | -$3.81K |
|
3734
Immersion
IMMR
$254M
| $2.23M | ﹤0.01% |
326,735
-297,437
| -48% | -$2.22M |
|
|
MMAT
3735
DELISTED
Meta Materials Inc. Common Stock
MMAT
| $2.23M | ﹤0.01% |
3,866
+2,303
| +147% | +$1M |
|
3736
Alnylam Pharmaceuticals
ALNY
$31.7B
| $2.23M | ﹤0.01% |
11,832
+1,711
| +17% | +$321K |
|
3737
Healthcare Realty
HR
$6.51B
| $2.23M | ﹤0.01% |
75,105
-1,871,200
| -96% | -$54.6M |
|
3738
iHeartMedia
IHRT
$426M
| $2.23M | ﹤0.01% |
89,016
-165,301
| -65% | -$4.07M |
|
3739
CALL
Baker Hughes
BKR
$62B
| $2.23M | ﹤0.01% |
+90,000
| New | +$2M |
|
3740
Farmers & Merchants Bancorp
FMAO
$472M
| $2.22M | ﹤0.01% |
99,172
-46,946
| -32% | -$1.05M |
|
3741
Avista
AVA
$3.15B
| $2.22M | ﹤0.01% |
56,739
-23,354
| -29% | -$978K |
|
|
GPGI
3742
GPGI Inc
GPGI
$3.84B
| $2.22M | ﹤0.01% |
264,345
+185,975
| +237% | +$1.56M |
|
3743
CALL
GrafTech
EAF
$193M
| $2.22M | ﹤0.01% |
+21,500
| New | +$2.35M |
|
|
EAC
3744
DELISTED
Edify Acquisition Corp. Class A Common Stock
EAC
| $2.22M | ﹤0.01% |
226,999
+170,000
| +298% | +$1.65M |
|
|
KC
3745
Kingsoft Cloud Holdings
KC
$3.19B
| $2.22M | ﹤0.01% |
78,243
-27,864
| -26% | -$827K |
|
|
HOLX
3746
CALL
DELISTED
Hologic
HOLX
| $2.21M | ﹤0.01% |
30,000
-76,100
| -72% | -$5.71M |
|
3747
Harrow
HROW
$1.4B
| $2.21M | ﹤0.01% |
243,585
-131,216
| -35% | -$1.19M |
|
3748
CALL
Hasbro
HAS
$13.3B
| $2.21M | ﹤0.01% |
+24,800
| New | +$2.41M |
|
3749
Tenaya Therapeutics
TNYA
$155M
| $2.21M | ﹤0.01% |
+106,851
| New | +$2.3M |
|
|
LFG
3750
DELISTED
Archaea Energy Inc.
LFG
| $2.21M | ﹤0.01% |
+116,415
| New | +$2.29M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.